A detailed history of Raymond James & Associates transactions in Elevance Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 271,927 shares of ELV stock, worth $107 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
271,927
Previous 268,561 1.25%
Holding current value
$107 Million
Previous $146 Million 2.83%
% of portfolio
0.09%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$500.12 - $562.29 $1.68 Million - $1.89 Million
3,366 Added 1.25%
271,927 $141 Million
Q2 2024

Jul 19, 2024

BUY
$497.49 - $547.8 $2.37 Million - $2.61 Million
4,756 Added 1.8%
268,561 $146 Million
Q1 2024

Apr 22, 2024

BUY
$464.61 - $519.96 $6.58 Million - $7.36 Million
14,161 Added 5.67%
263,805 $137 Million
Q4 2023

Jan 16, 2024

BUY
$433.51 - $488.06 $2.64 Million - $2.97 Million
6,081 Added 2.5%
249,644 $118 Million
Q3 2023

Oct 24, 2023

BUY
$414.13 - $475.93 $27.2 Million - $31.3 Million
65,719 Added 36.95%
243,563 $106 Million
Q2 2023

Jul 25, 2023

SELL
$436.33 - $496.2 $7.32 Million - $8.32 Million
-16,768 Reduced 8.62%
177,844 $79 Million
Q1 2023

Apr 14, 2023

BUY
$446.3 - $502.2 $14.5 Million - $16.4 Million
32,569 Added 20.1%
194,612 $89.5 Million
Q4 2022

Feb 08, 2023

BUY
$465.23 - $546.77 $5.68 Million - $6.68 Million
12,217 Added 8.15%
162,043 $83.1 Million
Q3 2022

Oct 25, 2022

SELL
$445.98 - $507.0 $2.96 Million - $3.36 Million
-6,635 Reduced 4.24%
149,826 $68.1 Million
Q2 2022

Aug 12, 2022

SELL
$444.32 - $529.84 $798,887 - $952,652
-1,798 Reduced 1.14%
156,461 $75.5 Million
Q1 2022

May 11, 2022

BUY
$428.44 - $502.48 $5.28 Million - $6.19 Million
12,327 Added 8.45%
158,259 $77.7 Million
Q4 2021

Feb 08, 2022

BUY
$370.08 - $467.67 $3.92 Million - $4.95 Million
10,584 Added 7.82%
145,932 $67.6 Million
Q3 2021

Nov 02, 2021

BUY
$357.51 - $398.13 $2.48 Million - $2.77 Million
6,950 Added 5.41%
135,348 $50.5 Million
Q2 2021

Aug 11, 2021

BUY
$352.19 - $401.9 $7.43 Million - $8.48 Million
21,098 Added 19.66%
128,398 $49 Million
Q1 2021

May 14, 2021

SELL
$287.7 - $371.31 $729,607 - $941,642
-2,536 Reduced 2.31%
107,300 $38.5 Million
Q4 2020

Feb 12, 2021

BUY
$270.17 - $333.15 $19,452 - $23,986
72 Added 0.07%
109,836 $35.3 Million
Q3 2020

Nov 04, 2020

SELL
$245.73 - $284.63 $361,223 - $418,406
-1,470 Reduced 1.32%
109,764 $29.5 Million
Q2 2020

Jul 28, 2020

BUY
$203.3 - $300.59 $1.09 Million - $1.61 Million
5,345 Added 5.05%
111,234 $29.3 Million
Q1 2020

Apr 21, 2020

BUY
$174.68 - $307.74 $544,652 - $959,533
3,118 Added 3.03%
105,889 $24 Million
Q4 2019

Feb 12, 2020

SELL
$234.82 - $306.42 $477,858 - $623,564
-2,035 Reduced 1.94%
102,771 $31 Million
Q3 2019

Nov 07, 2019

SELL
$237.69 - $310.48 $712,832 - $931,129
-2,999 Reduced 2.78%
104,806 $25.2 Million
Q2 2019

Aug 06, 2019

BUY
$236.25 - $293.76 $3.84 Million - $4.77 Million
16,233 Added 17.73%
107,805 $30.4 Million
Q1 2019

May 06, 2019

SELL
$248.42 - $317.42 $6.56 Million - $8.38 Million
-26,391 Reduced 22.37%
91,572 $26.3 Million
Q4 2018

Feb 11, 2019

BUY
$249.0 - $296.25 $6.49 Million - $7.72 Million
26,054 Added 28.35%
117,963 $31 Million
Q3 2018

Nov 14, 2018

BUY
$238.27 - $274.12 $1.76 Million - $2.03 Million
7,397 Added 8.75%
91,909 $25.2 Million
Q2 2018

Aug 14, 2018

BUY
$220.13 - $245.16 $3.33 Million - $3.71 Million
15,129 Added 21.81%
84,512 $20.1 Million
Q1 2018

May 14, 2018

SELL
$215.63 - $258.19 $2.35 Million - $2.82 Million
-10,907 Reduced 13.58%
69,383 $15.2 Million
Q4 2017

Feb 14, 2018

SELL
$183.76 - $234.96 $444,515 - $568,368
-2,419 Reduced 2.92%
80,290 $18.1 Million
Q3 2017

Nov 13, 2017

SELL
$181.44 - $197.43 $1.37 Million - $1.49 Million
-7,543 Reduced 8.36%
82,709 $15.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
90,252
90,252 $17 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $94.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.